PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway

Authors: Yilong Wang, Shu Yan, Xuemei Liu, Fei Deng, Pengchao Wang, Liuye Yang, Lizhi Hu, Kai Huang, Jiangui He - Cell Death and Differentiation 2022 cited by 310